HUTCHMED (China) Limited
General ticker "HMDCF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.8B (TTM average)
HUTCHMED (China) Limited follows the US Stock Market performance with the rate: 28.8%.
Estimated limits based on current volatility of 0.3%: low 3.01$, high 3.03$
Factors to consider:
- Total employees count: 2025 as of 2022
Short-term HMDCF quotes
Long-term HMDCF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $426.41MM | $838.00MM | $630.20MM |
| Operating Expenses | $839.64MM | $819.62MM | $670.81MM |
| Operating Income | $-413.23MM | $18.38MM | $-40.61MM |
| Non-Operating Income | $51.70MM | $87.23MM | $85.97MM |
| Interest Expense | $0.65MM | $0.76MM | $2.87MM |
| R&D Expense | $391.45MM | $302.00MM | $212.11MM |
| Income(Loss) | $-361.53MM | $105.60MM | $45.36MM |
| Taxes | $-0.28MM | $4.51MM | $7.19MM |
| Profit(Loss)* | $-360.83MM | $100.78MM | $37.73MM |
| Stockholders Equity | $610.37MM | $730.54MM | $759.93MM |
| Inventory | $56.69MM | $50.26MM | $50.38MM |
| Assets | $1,029.44MM | $1,279.77MM | $1,274.20MM |
| Operating Cash Flow | $-268.60MM | $219.26MM | $0.50MM |
| Capital expenditure | $36.66MM | $32.61MM | $17.93MM |
| Investing Cash Flow | $296.59MM | $-291.14MM | $-96.06MM |
| Financing Cash Flow | $-82.76MM | $48.66MM | $-30.67MM |
| Earnings Per Share** | $-0.43 | $0.12 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.